Biopharmaceutical Pipeline
Alzheimer’s Disease
5.7 Million
Americans who suffer with Alzheimers Disease
14 Million
Americans who will suffer with Alzheimers Disease by 2050
$25 Billion
Total Addressable Market by 2027
Americans who suffer with Alzheimers Disease
Americans who will suffer with Alzheimers Disease by 2050
Total Addressable Market by 2027